Learn More
Medchemexpress LLC Galeterone | 851983-85-2 | 99.9% | C26H32N2O | 200 MG

Supplier: Medchemexpress LLC HY70006200MG
Galeterone (TOK-001) is a potent, orally active molecular glue degrader that targets the androgen receptor (AR) and MAP kinase-interacting kinase (Mnk1/2). It also acts as a CYP17 inhibitor. Galeterone induces cell apoptosis and inhibits tumor growth in prostate cancer models, making it suitable for research in castration-resistant prostate cancer (CRPC) and pancreatic ductal adenocarcinoma (PDAC).
- Degrades androgen receptor (AR) and its splice variants (AR-Vs)
- Degrades MAP kinase-interacting serine/threonine protein kinase Mnk1/2
- Functions as a CYP17 inhibitor with an IC50 of 47 nM
- Induces cell apoptosis
- Inhibits tumor growth in human prostate cancer xenograft mouse models
- Potentially useful for research in castration-resistant prostate cancer (CRPC)
- Potentially useful for research in pancreatic ductal adenocarcinoma (PDAC)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.